Chemours reschedules Q4/FY 2023 earnings; cites internal control evaluation and Audit Committee review

Chemours Co

Earnings release postponed from Feb 14 to Feb 28, 2024; conference call moved to Feb 29.
Company needs extra time to complete year-end reporting; evaluating internal controls over financial reporting.
Audit Committee conducting an internal review related to information and communications.
Annual Report on Form 10-K expected to be filed by Feb 29, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.